Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    A Phase III Randomized, Double-Blind Trial of Chemoembolization with or without Sorafenib in Unresectable Hepatocellular Carcinoma (HCC) in Patients with and without Vascular Invasion
Show Display Options
Rank Status Study
1 Active, not recruiting Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Conditions: Hepatocellular Carcinoma;   Non-Resectable Hepatocellular Carcinoma
Interventions: Drug: Cisplatin;   Drug: Doxorubicin Hydrochloride;   Drug: Doxorubicin-Eluting Beads;   Other: Laboratory Biomarker Analysis;   Drug: Mitomycin;   Other: Pharmacological Study;   Other: Placebo;   Drug: Sorafenib Tosylate

Study has passed its completion date and status has not been verified in more than two years.